Nova (NVMI) Insider Yaniv Garty Buys 334 Shares

Insider Yaniv Garty added 334 shares of chip equipment maker Nova Ltd. (NASDAQ: NVMI) on June 18, 2026. The transaction was recorded at no cost per share, which typically points to an equity award or grant rather than an open-market purchase. This transaction was disclosed in a Form 4 filing with the Securities and Exchange Commission.

A Busy June for Nova Insiders

Garty’s acquisition was part of a larger wave of executive transactions at the company during the same week. On the very same day, June 18, 2026, Eitan Oppenhaim also received 1,043 shares at zero cost. However, Oppenhaim subsequently parted with 1,290 shares on June 22, 2026, at an average price of $581.20, resulting in a transaction value of $749,748. That sale was executed under a pre-arranged Rule 10b5-1 trading plan.

Other company insiders were active sellers during this period. On June 22, Zehava Simon and Sarit Sagiv each disposed of 366 shares at $581.20, with each trade totaling $212,719.20. Both insiders followed up the next day, June 23, by selling an additional 454 shares each. Those June 23 sales went through at an average price of $536.52 per share, bringing in $243,580.08 for each executive. All of these sales were carried out through scheduled trading plans.

Nova Stock Activity

On Monday, shares of the technology firm were trading at $583.10. The stock has experienced a wide trading range over the past year, moving between a low of $266.43 and a high of $615.99. Right now, the equity is trading significantly higher than its 50-day moving average of $392.10 and its 200-day moving average of $440.79. The company's valuation metrics show a price-to-earnings ratio of 45.29, while its forward P/E sits at 26.56, indicating expectations of stronger earnings ahead.

Financial Performance and Earnings

The company has posted strong financial metrics in its recent reporting periods. Nova generated annual revenue of $937.50 million, representing a year-over-year revenue growth rate of 15.9%. The business is highly profitable, boasting a net margin of 28.84% and a return on equity of 21.11%. Investors tracking the firm's financial progress can look forward to the next quarterly earnings release, which is scheduled for November 5, 2026.

Wall Street Adjustments for NVMI

Several research firms have updated their outlooks on Nova recently. On October 8, 2026, Citigroup lowered its stance on the stock, moving it from a Buy to a Neutral rating and lowering its price target to $415 from an earlier $550. This followed an August 10 update where Citigroup had kept a Buy rating but trimmed its target to $550 from $595. Other firms also adjusted their targets in August. On August 7, 2026, Needham kept its Buy rating but reduced its price target to $570 from $640. On the same day, Evercore ISI Group held onto its Outperform rating while reducing its target from $600 to $475, and Cantor Fitzgerald maintained an Overweight rating while lowering its target from $600 to $500. Earlier in the summer, on July 6, 2026, Morgan Stanley maintained its Equal-Weight rating and adjusted its price target to $540 from a prior $494. Overall, the consensus among eight analyst opinions is a strong buy, with an average price target of $532.00.

Process Control in the Chip Sector

Nova designs and manufactures high-tech metrology systems that are critical to semiconductor production. Its tools measure the dimensions and material properties of chips during various stages of manufacturing, helping chipmakers improve their yields and efficiency. Because these systems are vital for advanced chip design, the company's financial health is closely tied to overall capital spending in the global semiconductor industry.

What's Ahead for Nova Ltd.

The recent cluster of insider transactions highlights active portfolio management by Nova’s leadership team during a period of strong stock performance. Shareholders will likely keep a close eye on the upcoming November 5, 2026, earnings announcement to see if the company's operational growth justifies its current valuation. As always, insider trades and backward-looking regulatory filings are just pieces of the puzzle and should be evaluated alongside broader market trends.